Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms

Published:2011-12 Issue:6 Volume:4 Page:619-625
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Tesfa Daniel,Palmblad Jan

Publisher

Informa UK Limited

Subject

Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1586/ehm.11.62

Reference46 articles.

1. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

2. Rituximab therapy in malignant lymphoma

3. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

4. Rituximab: Mechanism of Action

5. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-cell Depletion Therapy in Pediatric Neuroinflammatory Disease;Current Neurology and Neuroscience Reports;2024-09-11

2. Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis;Journal of Multiple Sclerosis and Neuroimmunology;2024-06-30

3. Antibody-Based Biotherapeutics in Cancer;Pharmaceutical Biotechnology;2024

4. Idiosyncratic drug reactions and toxicities;Public Health and Toxicology Issues Drug Research, Volume 2;2024

5. Toxic effects of cancer therapies;Public Health and Toxicology Issues Drug Research, Volume 2;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP